Hypertension

Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program

CirculationPublished Patient-level pooled analysis of the RADIANCE randomised trials

Pooled result · Daytime ambulatory SBP (baseline- and medication-adjusted)Result — go to the resultBetween-group difference −3.0 mm Hg 95% CI −5.7 to −0.2

Authors' conclusion

This individual patient-data analysis of 506 patients included in the RADIANCE trials demonstrates the maintenance of BP-lowering efficacy of uRDN versus sham at 6 months, with fewer added AHTs.

Study context

Population
Patients with mild to moderate hypertension not on AHT or with hypertension resistant to standardized triple AHT
Participants
506 patients · 3 trials
Comparison
Ultrasound renal denervation (uRDN) vs Sham
  • uRDNn = 293
  • Shamn = 213reference
Outcome
Baseline- and AHT-adjusted change in daytime ambulatory SBP
Follow-up
6 months
Methodological detailssham-controlled, individual patient data, Blinded sequential addition of standardized AHT from 2 to 5 months if home blood pressure (BP) ≥135/85 mm Hg
  • Sham-controlled
  • Individual patient data
  • Blinded sequential addition of standardized AHT from 2 to 5 months if home BP ≥135/85 mm Hg

Pooled result

As reported in the abstract

Daytime ambulatory SBP (baseline- and medication-adjusted)

Between-group difference

−3.0 mm Hg

95% CI −5.7 to −0.2

P = 0.033

uRDN vs Sham
between-group difference −3.0 mm Hg (95% CI −5.7 to −0.2); P = 0.033

Further pooled results

OutcomeBetween-group difference (mm Hg) (CI)P value
Home SBP (adjusted) · over 6 months−5.4 (−6.8 to −4.0)P < 0.001
Office SBP (adjusted) · over 6 months−5.2 (−7.1 to −3.3)P < 0.001

AHT prescription · 2 to 6 months

Fewer uRDN patients prescribed AHT
P = 0.004
Fewer additional AHT prescribed with uRDN vs sham
P = 0.001

Safety

Safety outcomes · 6 months

Safety outcomes were few and did not differ between groups

Original publication

Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program. Circulation. Published 26 October 2023. doi:10.1161/circulationaha.123.066941

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.